APA (7th ed.) Citation

DJ, P., A, D., CAM, F., AE, S., C, C., S, K., . . . R, S. (2024). Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research, 30(11), 2433. https://doi.org/10.1158/1078-0432.CCR-24-0177

Chicago Style (17th ed.) Citation

DJ, Pinato, et al. "Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 30, no. 11 (2024): 2433. https://doi.org/10.1158/1078-0432.CCR-24-0177.

MLA (9th ed.) Citation

DJ, Pinato, et al. "Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 30, no. 11, 2024, p. 2433, https://doi.org/10.1158/1078-0432.CCR-24-0177.